75
Views
3
CrossRef citations to date
0
Altmetric
Meta-Analysis

Association of E-Selectin gene rs5361 polymorphism with ischemic stroke susceptibility: a systematic review and Meta-analysis

, , , , &
Pages 511-517 | Received 02 Jan 2019, Accepted 11 Mar 2020, Published online: 13 Apr 2020

References

  • World Health Organization. The world health report. World Health or ganization: Geneva; 1999.
  • Chen HL, Hua Q, Liu RK, et al. Effect of E-selectin A561C (S128R) polymorphism on blood pressure. Zhonghua Xin Xue Guan Bing Za Zhi. 2005;33:603–607.
  • Liao B, Chen K, Xiong W, et al. Relationship of SELE A561C and G98T variants with the susceptibility to CAD. Medicine (Baltimore)). 2016;95(8):e1255.
  • Bannan S, Mansfield MW, Grant PJ. Soluble vascular cell adhesion molecule-1 and E-selectin levels in relation to vascular risk factors and to E-selectin genotype in the first degree relatives of NIDDM patients and in NIDDM patients. Diabetologia. 1998;41(4):460–466.
  • Mlekusch W, Exner M, Schillinger M, et al. E-Selectin and restenosis after femoropopliteal angioplasty: prognostic impact of the Ser128Arg genotype and plasma levels. Thromb Haemost. 2004;91(01):171–179.
  • Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
  • Wells G, Shea B, O’Connell D, et al. The New-castle-Ottawa Scale (NOS) for assessing the quality of non-Q2 randomized studies in meta-analyses. 2011; http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp [accessed 10 November, 2018]
  • Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statist Med. 2002;21(11):1539–1558.
  • Zintzaras E, Ioannidis JP. Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol. 2005;28(2):123–137.
  • Martin WJ. Statistical aspects of poliomyelitis in England and Wales in recent years. Mon Bull Minist Health Public Health Lab Serv. 1959;18:54–64.
  • Egger M, Smith GD, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634.
  • Hattori H, Sato H, Ito D, et al. A561C polymorphism of E-selectin is associated with ischemic cerebrovascular disease in the Japanese population without diabetes mellitus and hypercholesterolemia. Brain Res. 2006;1108(1):221–223.
  • Tang TT, Ren TL, Zhang YL. Association between A561C polymorphism E-selectin and 176 patients stroke. Shandong Med J. 2011;51(11):77–78.
  • Xie J, Gao HC, Zhao W, et al. Relationship between polymorphisms of E-selectin gene and Kazak patient with cerebral infarction in Xinjiang. Prog Mod Biomed. 2011;11(6):1102–1105.
  • Chen JN, Wei GY, Fu XL, et al. Relationship of E-selectin A561C gene polymorphisms in patients with cerebral infarction and its effecton plasma lipid level. Chin J Modern Med. 2010;20(16):2468–2470.
  • Luo D. Association between E-Selectin S128R polymorphism and the risk of stroke. Med Inform. 2013;16:326–327.
  • Wei YS, Lan Y, Du SK. Distribution of E-selectin gene polymorphism in the Zhuangs and Hans of Guangxi province in China. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004;21(6):643–645.
  • Flex A, Gaetani E, Papaleo P, et al. Proinflammatory genetic profiles in subjects with history of ischemic stroke. Stroke. 2004;35(10):2270–2275.
  • Zhao DX, Feng J, Cong SY, et al. Association of E-selectin gene polymorphisms with ischemic stroke in a Chinese Han population. J Neurosci Res. 2012;90(9):1782–1787.
  • Haidari M, Hajilooi M, Rafiei AR, et al. E-selectin genetic variation as a susceptibility factor for ischemic stroke. Cerebrovasc Dis. 2009;28(1):26–32.
  • Motawi T, Shaker O, Taha N, et al. Genetic variations in E-selectin and ICAM-1: relation to atherosclerosis. Med Sci Monit. 2012;18(6):CR381–389.
  • Roy S, Das S, Danaboina R, et al. Association of E-selectin gene polymorphism (S128R) with ischemic stroke and stroke subtypes. Inflammation. 2014;37(2):599–603.
  • Ma LY, Zhao Y, Wang XY, et al. Analysis between ischemic stroke ELAM-1gene Ser128Arg polymorphismin the Beijing area. Shandong Med J. 2000;40:12–13.
  • Wang F, Liu RZ, Liu ZW. Association of plasma E-Selectin Gene S128R polymorphism and cerebral infarction in Shanxi Han population. Chin J Integr Med Cardio-/Cerebrovasc Dis. 2010;8:549–551.
  • Shebuski RJ, Kilgore KS. Role of inflammatory mediators in thrombogenesis. J Pharmacol Exp Ther. 2002;300(3):729–735.
  • Blake GJ, Ridker PM. Novel clinical markers of vascular wall inflammation. Circ Res. 2001;89(9):763–771.
  • Wenzel K, Hanke R, Speer A. Polymorphism in the human E-selectin gene detected by PCR-SSCP. Hum Genet. 1994;94(4):452–453.
  • Yoshida M, Takano Y, Sasaoka T, et al. E-selectin polymorphism associated with myocardial infarction causes enhanced leukocyte-endothelial interactions under flow conditions. Atvb. 2003;23(5):783–788.
  • Wenzel K, Ernst M, Rohde K, et al. DNA polymorphisms in adhesion molecule genes–a new risk factor for early atherosclerosis. Hum Genet. 1996;97(1):15–20.
  • Issac MS, Afif A, Gohar NA, et al. Association of E-selectin gene polymorphisms and serum PAPP-A with carotidatherosclerosis in end-stage renal disease. Mol Diagn Ther. 2014;18(2):243–252.
  • Hackman A, Yasunori A, Insull W, et al. Levels of soluble cell adhesion molecules in patients with dyslipidemia. Circulation. 1996;93(7):1334–1338.
  • Huang J, Choudhri TF, Winfree CJ, et al. Post-ischemic cerebrovascular E-selectin expression mediates tissue injury in murine stroke. Stroke. 2000;31(12):3047–3053.
  • Wang Q, Zhao W, Bai S. Association between plasma soluble P-selectin elements and progressive ischemic stroke. Exp Ther Med. 2013;5(5):1427–1433.
  • Collins RG, Velji R, Guevara NV, et al. P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice. J Exp Med. 2000;191(1):189–194.
  • Endler G, Exner M, Raith M, et al. The Eselectin S128R polymorphism is not a risk factor for coronary artery disease in patients with diabetes mellitus type 2. Thromb Res. 2003;112(1-2):47–50.
  • Haller H. Endothelial function. General Considerations. Drugs. 1997;53(Supplement 1):1–10.
  • Ghazouani L, Abboud N, Khalifa SB, et al. Contribution of SELP and PSGL-1 genotypes and haplotypes to the presence of coronary heart disease in Tunisians. Mol Biol Rep. 2011;38(1):495–501.
  • Sandoval-Pinto E, Padilla-Gutierrez JR, Valdes-Alvarado E, et al. Assessment of the E-selectin rs5361 (561 A&C) polymorphism and soluble protein concentration in acute coronary syndrome: association with circulating levels. Mediat Inflamm. 2014;2014:1–10.
  • Miller MA, Kerry SM, Dong Y, et al. Circulating soluble E-selectin levels and the Ser128Arg polymorphism in individuals from different ethnic groups. Nutr Metab Cardiovasc Dis. 2005;15(1):65–70.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.